Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

New Research from Allergan Reveals that the Quest to Look Younger is No Longer a Beauty Priority for Women


News provided by

Allergan

16 Dec, 2014, 07:30 GMT

Share this article

Share toX

Share this article

Share toX

This image opens in the lightbox
Juliet Keeble took part in the social experiment conducted by Allergan for their #ThisIsMe campaign. Her image was retouched to different degrees - from natural, to subtle wrinkle softening, to magazine style flawlessness. (PRNewsFoto/Allergan)
This image opens in the lightbox
Juliet Keeble took part in the social experiment conducted by Allergan for their #ThisIsMe campaign. Her image was retouched to different degrees - from natural, to subtle wrinkle softening, to magazine style flawlessness. (PRNewsFoto/Allergan)
This image opens in the lightbox
Juliet Keeble took part in the social experiment conducted by Allergan for their #ThisIsMe campaign. Her image was retouched to different degrees - from natural, to subtle wrinkle softening, to magazine style flawlessness. (PRNewsFoto/Allergan)
This image opens in the lightbox
Juliet Keeble took part in the social experiment conducted by Allergan for their #ThisIsMe campaign. Her image was retouched to different degrees - from natural, to subtle wrinkle softening, to magazine style flawlessness. (PRNewsFoto/Allergan)

MARLOW, England, December 16, 2014 /PRNewswire/ --

New research conducted by Allergan, the maker of JUVÉDERM® facial fillers, has revealed that even when surrounded by images of smooth faced-celebrities, most women don't want to erase all their lines and wrinkles.[i] In fact, given the chance to transform into a younger looking version of themselves, most women would choose not to do so.[i]

     (Photo: http://photos.prnewswire.com/prnh/20141216/721011-a )
     (Photo: http://photos.prnewswire.com/prnh/20141216/721011-b )
     (Photo: http://photos.prnewswire.com/prnh/20141216/721011-c )
     (Photo: http://photos.prnewswire.com/prnh/20141216/721011-d )

This refreshing attitude to ageing was put to the test when Allergan assembled a panel of women in their early 50s to find out just how many would be able to resist the temptation of a wrinkle-free complexion. During the experiment, the panel were photographed and their images retouched to different degrees - from subtle wrinkle softening, to magazine style flawlessness. Despite being faced with a vision of themselves that appeared years younger, all of the women preferred the image that they felt represented the way they feel inside: the one that kept most of their lines, but not all of them.[i]

The surprising results were reinforced by public preference as well. When shown the images, on average nearly two thirds (63%)* of the 2,000 women surveyed said the participants looked better with most of their wrinkles intact and with only subtle tweaks made to their appearance.[i] Nearly two in three respondents (64%), thought the images of the women with a few wrinkles softened looked refreshed and 69% thought they looked good for their age.[i]

On average almost half (47%) thought the totally retouched images looked unnatural and a further 41% thought the most retouched images didn't look real.[i] This revelation debunks the myth that women want to look younger - according to this research, they just want to look like the best version of themselves.

Honey Langcaster-James, Behavioural Psychologist, attended the experiment and assessed the attitudes of the women involved: "As more milestones pass, women feel that the face in the mirror isn't a true reflection of how the vital, energetic person they feel like on the inside and yet the outside world is also full of unrealistic and youthful faces that they don't identify with either.  What's really interesting is that women today don't want to look years younger; they want to age well which for them, means looking great for their age. All of the women who took part in the experiment showed just that- subtle tweaks is all they wanted and they were adamant that they wanted to still look like 'them'."

Commenting on the results of the social experiment Dr  Jonquille Chantrey, plastic surgeon, said: "I see women and men every day who just want to soften one or two tell-tale lines or wrinkles that are bothering them about their appearance. More people are choosing less invasive treatments with dermal fillers as it's possible to achieve a very natural and refreshed look. This subtle, more attractive result conveys a healthy approach to life choices, rather than wanting to look young."

Debbie Christian, a participant in the social experiment, said: "I like some of my wrinkles as they add to my character, but others I can do without. I feel great on the inside and the image which I chose as my favourite still looked exactly like me, just with subtle tweaks, which refreshed my look. I would never want to look totally flawless at my age, that's not realistic and I would just look fake."

The experiment is part of a wider communications campaign called #THISISME, which celebrates women's choices to age well, by embracing the lines they like and saying goodbye to the ones they don't. For more information on the campaign or on Juvéderm facial fillers, visit http://www.this-is-me.com or http://www.juvederm.co.uk.

[i] Opinium Research, November 2014, commissioned by Allergan UK. Online survey of 2,029 UK females aged 18+.
* This statistic was calculated by taking an average percentage for each respondent who ranked either image 2 (slightly retouched) or image 3 (modestly retouched) as being the best version (top rank) of any of the four women.

Notes to editors: 

Additional research statistics available on request.

About JUVÉDERM® 

As we get older, our skin loses volume, elasticity and tone, causing some of the tell-tale signs of visible ageing. Facial fillers like those in the JUVÉDERM® range, simply replace lost volume using the same naturally found ingredient, HA, that is lost from the skin as we age. The entire JUVÉDERM® range of products have been authorised for use in Europe and each product carries the European registration stamp, the CE Mark. Allergan is firmly committed to science, innovation and quality, and that's why each product within the range has been thoroughly tested in clinical trials. Allergan is deeply committed to practitioner training and has launched the Allergan Medical Institute to ensure qualified practitioners know how to use the JUVÉDERM® products to help restore lost volume and create natural looking, subtle results.

About Allergan 

Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meaningful treatments to help people reach their life's potential. Today, we have approximately 11,500 highly dedicated and talented employees, global marketing and sales capabilities with a presence in more than 100 countries, a rich and ever-evolving portfolio of pharmaceuticals, biologics, medical devices and over-the-counter consumer products, and state-of-the-art resources in R&D, manufacturing and safety surveillance that help millions of patients see more clearly, move more freely and express themselves more fully. From our beginnings as an eyecare company to our focus today on several medical specialties, including eyecare, neurosciences, medical aesthetics, medical dermatology, breast aesthetics, and urologics, Allergan is proud to celebrate more than 60 years of medical advances and proud to support the patients and customers who rely on our products and the employees and communities in which we live and work.

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.